Dergiler / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 7

Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease

Sayfa
611–615
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The renal function of NAFLD patients should be closely monitored.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: This study investigated an association between obesity and impaired renal functions in elderly patients with nonalcoholic fatty liver disease (NAFLD) and evaluated the risk factors for chronic kidney disease (CKD) in these patients.Materials and Methods: A cross-sectional study was performed involving 515 elderly patients (≥ 60 years old) with NAFLD.
📊
Temel Bulgular & Veri:Demographics, body mass index (BMI), medical history, and laboratory parameters were compared for groups stratified by obesity (≥ 28 kg/m2)or CKD.
💡
Sonuç & Katkı:The renal function of NAFLD patients should be closely monitored.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: This study investigated an association between obesity and impaired renal functions in elderly patients with nonalcoholic fatty liver disease (NAFLD) and evaluated the risk factors for chronic kidney disease (CKD) in these patients.Materials and Methods: A cross-sectional study was performed involving 515 elderly patients (≥ 60 years old) with NAFLD. Demographics, body mass index (BMI), medical history, and laboratory parameters were compared for groups stratified by obesity (≥ 28 kg/m2)or CKD. An association between obesity and CKD was analyzed, and a multivariate logistic regression analysis was conducted for riskfactors associated with CKD.Results: In the overall population, 28.7% were obese and 54.8% had CKD; there were more women (58.8%) than men. The prevalenceof hypertension and diabetes was similar between the obese and nonobese groups and between the CKD and non-CKD groups. Obesepatients had significantly higher levels of serum uric acid and estimated glomerular filtration rates when compared with the nonobesegroup. When compared with those without CKD, patients with CKD were significantly older in addition to having higher BMI and serumuric acid levels. The multivariate logistic regression analysis indicated that CKD was positively associated with age, BMI, and serum uricacid levels.Conclusion: Elderly obese patients with NAFLD are at a higher risk of CKD. NAFLD patients with advanced age, greater BMI, or higherserum uric acid levels are more prone to developing CKD. The renal function of NAFLD patients should be closely monitored.

🔖

Bu Makaleye Atıf Yap

LUO, K., BIAN, J., WANG, Q., WANG, J., CHEN, F., LI, H., JIN, D. (2019). Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 7, 611–615. https://ajindex.com/articles/408823

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol 2017
  2. [CrossRef] 2. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010
  3. [CrossRef] 3. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012
  4. [CrossRef] 4. Streba LA, Vere CC, Rogoveanu I, Streba CT. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. World J Gastroenterol 2015
  5. [CrossRef] 5. Itoh M, Suganami T, Hachiya R, Ogawa Y. Adipose tissue remodeling as homeostatic inflammation. Int J Inflam 2011
  6. 720926. [CrossRef] 6. Yilmaz Y, Younossi ZM. Obesity-associated nonalcoholic fatty liver disease. Clin Liver Dis 2014
  7. [CrossRef] 7. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 2006
  8. [CrossRef] 8. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol 2013
  9. [CrossRef] 9. Vinhas J, Gardete-Correia L, Boavida JM, et al. Prevalence of chronic kidney disease and associated risk factors, and risk of endstage renal disease: data from the PREVADIAB study. Nephron Clin Pract 2011
  10. c35-40. [CrossRef] 10. Koye DN, Shaw JE, Reid CM, Atkins RC, Reutens AT, Magliano DJ. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Diabet Med 2017
  11. [CrossRef] 11. Targher G, Byrne CD. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol 2017
  12. [CrossRef] 12. Yasui K, Sumida Y, Mori Y, et al. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. Metabolism 2011
  13. [CrossRef] 13. Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003
  14. [CrossRef] 14. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 2010
  15. [CrossRef] 15. Marcuccilli M, Chonchol M. NAFLD and Chronic Kidney Di